I have been following MDR for a umber of months. Maybe someone here can help me out on their revenue model as I have been over a number of announcements and haven't really found any reference to how they derive their income stream.
Annually report suggests the made $1.43M through tap to refill. How does the company make its money. Is it through licenses, or per prescription refill.
$75M annualised prescription revenue through the platform and $1.43M sales revenue is less than 2% on sales throughput. Isn't this rather low?
Any help on the revenue models anyone can give me would be much appreciated.
Ann: MedAdvisor AGM CEO Presentation-MDR.AX, page-5
Add MDR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39326 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 2917 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MDR (ASX) Chart |
